Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Wellpoint announces third quarter 2009 financial results; net income is 1.53 per share

WellPoint, Inc. (NYSE: WLP) today announced that third quarter 2009 net income was $730.2 million, or $1.53 per share, including net investment gains of $21.5 million pre-tax, or $0.03 per share, and an impairment charge totaling $205.5 million pre-tax, or $0.28 per share, for certain intangible assets.

28 Oct 2009

HHS selects Smiths Medical to supply safety hypodermic syringes

Smiths Medical announced today that it has been selected for a contract award from the U.S. Department of Health and Human Services (HHS) for safety hypodermic syringes that could reach $10 million. The award is part of the government’s national flu pandemic preparedness efforts.

28 Oct 2009

SSSP software to detect spoiled food

Let's start with an example: You have just picked up a pack of cold-smoked salmon from the supermarket chill cabinet to serve for your family lunch on Sunday. On its way from the factory to the lunch table, the salmon product has been exposed to varying temperatures. Now, how can you be sure the product is still good to eat when you take it out of the refrigerator to make sandwiches?

28 Oct 2009

3M launches new Rapid Detection Respiratory Syncytial Virus Test

Expanding its platform of rapid diagnostic testing, 3M today announced the introduction of the 3M™ Rapid Detection RSV Test. RSV, or respiratory syncytial virus, is a respiratory virus that infects the lungs and breathing passages and is a common cause of bronchitis and pneumonia in children under one year.

28 Oct 2009

Dementia patients face higher risk of flu mortality; refine guidelines needed for testing and vaccination policies

An epidemiological study on pneumonia and influenza (P&I) in adults age 65 and over reports that patients with dementia are diagnosed with flu less frequently, have shorter hospital stays, and have a fifty percent higher rate of death than those without dementia.

28 Oct 2009

Microbix and Hunan Biopharmaceutical to build $200-million influenza vaccine facility

Microbix, a developer of a patented technology that doubles the output of influenza vaccine production, announced today it has signed a joint venture agreement with the Hunan Biopharmaceutical Co. Ltd. (a Hunan Province state-owned enterprise) for initial financing to construct Asia's largest influenza vaccine production facility and the third largest vaccine plant in the world.

28 Oct 2009

D3 FastPoint L-DFA Influenza A/ Influenza B Virus Identification Kit receives FDA clearance

Diagnostic Hybrids, a leading developer of in vitro diagnostic fluorescent staining kits and cell culture products, announces the U.S. Food and Drug Administration (FDA) (510k) clearance of its D3 FastPointTM L-DFATM Influenza A/ Influenza B Virus Identification Kit, which allows for the identification of influenza A virus and influenza B virus from a patient’s specimen in under 30 minutes.

28 Oct 2009

Nasopharyngeal Flocked Swabs are recommended for H1N1 and influenza A testing

Preparing for this flu season, the American Society for Microbiology (ASM) PSAB Committee on Laboratory Practices has recently published a new interim algorithm providing guidance to clinical laboratories responsible for testing patients with respiratory illness for Influenza A, including H1N1.

28 Oct 2009

Drug-cocktail approach offers hope in developing single agent to treat drug-resistant H1N1 swine flu

An experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher in the University of Alabama Birmingham (UAB) Division of Pediatric Infectious Diseases.

28 Oct 2009

HMSMobile Swine Flu Center application to provide information on H1N1 virus introduced

The HMSMobile Swine Flu Center, a new iPhone application developed by the Harvard Health Publications Division of Harvard Medical School, is now available for purchase in the iTunes store.

28 Oct 2009

H1N1 overwhelms hospitals; Sebelius addresses flu vaccine shortage

Hospitals across the country are overwhelmed "as waves of flu patients arrive at their doors, doubling their emergency room volume," USA Today reports. "Just as significant is the effect on intensive care units: A relatively small number of flu patients are requiring intensive care, but some are so ill they will need round-the-clock care for weeks.

27 Oct 2009

More people rely on alternative medicine

As consumers look to save money in a tough economy, many turn to alternative health care options. CBS 4 reports: "Health care costs are soaring. Thousands of people are without jobs and without the benefits afforded them. Now, those people are turning to preventative or alternative measures. ... The National Center for Complimentary and Alternative Medicine (NCCAM) shows 38 percent of adults and 12 percent of kids are now using alternative therapies to treat pain. In fact, Americans are now reportedly spending $34 billion a year on alternative therapies" (Demos, 10/26).

27 Oct 2009

SDC-based hard surface disinfectant is effective against the 2009 H1N1

PURE Bioscience, creators of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that its SDC-based hard surface disinfectant is effective against the 2009 H1N1 and is included on the list published by the U.S. Environmental Protection Agency (EPA) of antimicrobial products effective against the 2009 H1N1 flu strain based on their effectiveness against other influenza A virus strains.

27 Oct 2009

Hope for lung cancer patients

Lung cancer is the world's most common cancer, and an estimated 219,440 Americans are expected to be diagnosed this year. It is also estimated that lung cancer will cause 159,000 deaths in the United States this year - more than the total number of deaths resulting from breast, colon and prostate cancers combined.

27 Oct 2009

Inverness Medical Innovations announces its financial results for the third-quarter

Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced its financial results for the quarter ended September 30, 2009.

27 Oct 2009

China places third purchase order for H1N1 vaccine with Sinovac Biotech

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has received its third purchase order for its H1N1 vaccine, PANFLU.1, from China's Ministry of Industry and Information Technology for the national stockpiling plan.

27 Oct 2009

Life Technologies reports third quarter 2009 results; non-GAAP and organic revenues increase by 3% and 5%

Life Technologies Corporation (NASDAQ:LIFE) today announced results for its third quarter ended September 30, 2009. Non-GAAP revenue for the third quarter was $805 million, an increase of 3 percent over third quarter revenue of $784 million in 2008, as if Invitrogen and Applied Biosystems had been combined.

From Danaher 27 Oct 2009

New hygienic cutlery dispenser, DIXIE SmartStock, aids in fight against germs

Flu season is in full swing, and high-traffic establishments such as foodservice facilities must take preventive measures to ensure a hygienic and safe environment for their customers. Georgia-Pacific Professional Food Services Solutions is aiding in the fight against germs with its hygienic cutlery dispenser, DIXIE® SmartStock®.

27 Oct 2009

Boston Medical Center deploys Fusionfx Immunization Management portal to manage H1N1 vaccination

Acknowledging the critical role of Centers for Disease Control and Prevention (CDC) guidelines in ensuring the safety and efficacy of H1N1 vaccinations, Carefx Corporation, a leading provider of interoperable workflow solutions to advance the quality and safety of patient care, today announced that Boston Medical Center (BMC) has deployed the Fusionfx Immunization Management portal designed to enter and track H1N1 vaccination administration history and support broad, community-wide immunization administration tracking.

27 Oct 2009

New anti-flu drugs to fight flu virus could become a reality

New anti-flu drugs could become a reality as a result of a study carried out by academics at the University of Hertfordshire.

27 Oct 2009

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Wellpoint announces third quarter 2009 financial results; net income is 1.53 per share

HHS selects Smiths Medical to supply safety hypodermic syringes

SSSP software to detect spoiled food

3M launches new Rapid Detection Respiratory Syncytial Virus Test

Dementia patients face higher risk of flu mortality; refine guidelines needed for testing and vaccination policies

Microbix and Hunan Biopharmaceutical to build $200-million influenza vaccine facility

D3 FastPoint L-DFA Influenza A/ Influenza B Virus Identification Kit receives FDA clearance

Nasopharyngeal Flocked Swabs are recommended for H1N1 and influenza A testing

Drug-cocktail approach offers hope in developing single agent to treat drug-resistant H1N1 swine flu

HMSMobile Swine Flu Center application to provide information on H1N1 virus introduced

H1N1 overwhelms hospitals; Sebelius addresses flu vaccine shortage

More people rely on alternative medicine

SDC-based hard surface disinfectant is effective against the 2009 H1N1

Hope for lung cancer patients

Inverness Medical Innovations announces its financial results for the third-quarter

China places third purchase order for H1N1 vaccine with Sinovac Biotech

Life Technologies reports third quarter 2009 results; non-GAAP and organic revenues increase by 3% and 5%

New hygienic cutlery dispenser, DIXIE SmartStock, aids in fight against germs

Boston Medical Center deploys Fusionfx Immunization Management portal to manage H1N1 vaccination

New anti-flu drugs to fight flu virus could become a reality

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in